Viewing Study NCT03212404

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:16 PM

Ignite Modification Date: 2026-01-02 @ 10:27 AM

Study NCT ID: NCT03212404

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-02-03

First Post: 2017-07-06

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Sponsor: Checkpoint Therapeutics, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module